Hepion Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2013 to 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Hepion Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2024.
Hepion Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2025 was -$1.75M, a 79.5% increase year-over-year.
Hepion Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2025 was -$8.69M, a 75% increase year-over-year.
Hepion Pharmaceuticals, Inc. annual Operating Income (Loss) for 2024 was -$19.3M, a 60.1% increase from 2023.
Hepion Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$48.4M, a 6.51% decline from 2022.
Hepion Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$45.5M, a 49.6% decline from 2021.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Annual (USD)

Operating Income (Loss), YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2024	-$19.3M	+$29.1M	+60.1%	Jan 1, 2024	Dec 31, 2024	10-K	2025-04-08
2023	-$48.4M	-$2.96M	-6.51%	Jan 1, 2023	Dec 31, 2023	10-K	2025-04-08
2022	-$45.5M	-$15.1M	-49.6%	Jan 1, 2022	Dec 31, 2022	10-K	2024-04-16
2021	-$30.4M	-$10.3M	-50.9%	Jan 1, 2021	Dec 31, 2021	10-K	2023-04-10
2020	-$20.1M	-$12.4M	-159%	Jan 1, 2020	Dec 31, 2020	10-K	2022-04-08
2019	-$7.77M	+$6.82M	+46.8%	Jan 1, 2019	Dec 31, 2019	10-K	2021-03-31
2018	-$14.6M	+$6.05M	+29.3%	Jan 1, 2018	Dec 31, 2018	10-K	2020-05-14
2017	-$20.6M	+$159K	+0.77%	Jan 1, 2017	Dec 31, 2017	10-K	2019-03-14
2016	-$20.8M	-$6.85M	-49%	Jul 1, 2015	Jun 30, 2016	10-KT	2018-03-26
2015	-$14M	-$12.3M	-735%	Jul 1, 2014	Jun 30, 2015	10-K	2016-09-28
2014	-$1.67M	-$729K	-77.4%	Jul 1, 2013	Jun 30, 2014	10-K	2015-09-25
2013	-$943K			May 15, 2013	Mar 31, 2014	10-Q	2014-05-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.